Pharma Mar S.A. | Ownership
Companies that own Pharma Mar S.A.
The Vanguard Group, Inc.
3,961,362
1.78%
-884
0%
07/31/2018
Norges Bank Investment Management
3,926,609
1.76%
407,935
0%
12/31/2017
BlackRock Fund Advisors
2,132,378
0.96%
0
0%
09/06/2018
Dimensional Fund Advisors LP
1,435,620
0.65%
-50,480
0%
04/30/2018
JPMorgan Asset Management (UK) Ltd.
1,128,176
0.51%
-533,983
0%
05/31/2018
Santander Asset Management SA SGIIC
1,004,069
0.45%
-1,024,247
0.02%
12/31/2017
Trea Asset Management SGIIC SA
851,971
0.38%
25,925
0.13%
03/31/2018
Bankia Fondos SGIIC SA
738,251
0.33%
-270,204
0.02%
12/31/2017
APG Asset Management NV
606,796
0.27%
-1,106
0%
03/31/2018
Bankinter Gestión de Activos SA SGIIC
592,877
0.27%
12,299
0.02%
03/31/2018
| Address |
Avenida de los Reyes, 1
Colmenar Viejo Madrid 28770
Spain
|
|
Employees
|
- |
| Website |
http://www.pharmamar.es |
| Updated |
07/08/2019 |
| Pharma Mar SA is a biopharmaceutical holding company, which engages in discovery and development of innovative marine-derived anticancer drugs. It operates through the following segments: Oncology, Diagnostics, RNAi, and Consumer Chemicals. The Oncology segment encompasses the Group undertakings whose object is to research, develop and market anti-tumour drugs. |
